China Shineway Pharmaceutical Group Limited (CSWYY)

OTCMKTS · Delayed Price · Currency is USD
19.25
+0.72 (3.89%)
At close: May 13, 2025
Market Cap816.61M +19.0%
Revenue (ttm)448.28M -17.0%
Net Income135.82M +13.1%
EPS0.18 +13.3%
Shares Out n/a
PE Ratio6.01
Forward PE5.79
Dividend1.42 (7.36%)
Ex-Dividend DateMay 5, 2026
Volume100
Open19.25
Previous Close18.53
Day's Range19.25 - 19.25
52-Week Range18.53 - 19.25
Beta0.83
Analystsn/a
Price Targetn/a
Earnings DateMar 27, 2026

About CSWYY

China Shineway Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and trade of Chinese pharmaceutical products in the People’s Republic of China and Hong Kong. The company offers Chinese medicines in the form of injection, soft capsules, and granules; and other dosage forms, including pills and tablets; and traditional Chinese medicine granules in various therapeutic areas, including respiratory system disease, nervous system, digestive system disease, cardiovascular and cerebrovas... [Read more]

Sector Healthcare
Founded 2002
Employees 2,822
Stock Exchange OTCMKTS
Ticker Symbol CSWYY

Financial Performance

In 2025, CSWYY's revenue was 3.14 billion, a decrease of -17.01% compared to the previous year's 3.78 billion. Earnings were 949.95 million, an increase of 13.08%.

Financial numbers in CNY Financial Statements